US Brain Metastasis Therapeutic Market Advances in Targeted Therapies
The U.S. brain metastasis therapeutic market is driven by the increasing incidence of cancer-related brain metastases, advances in targeted therapies and immunotherapy, and growing adoption of precision oncology. The availability of advanced treatment options, established healthcare infrastructure, and significant investment in cancer research are supporting market growth. Rising demand for...
0 Commenti 0 condivisioni 102 Views 0 Anteprima